CompletedNot Applicable

Effect of Myofacial Release vs. Eccentric Resistance on Pain, ROM and Functional Disability on Achilles Tendonitis

Pakistan72 participantsStarted 2022-09-19

Plain-language summary

Achilles tendinitis is a common condition that cause pain along back of leg near the heal. It is an overuse injury of the Achilles tendon, the band of tissue that connect calf muscles at the back of the lower leg to heel bone. There are number of treatment approaches to relieve pain in Achilles tendonitis . Insufficient literature has discuss the combine effect of myofascial release with eccentric resistance. So the aim of the study is to compare the effect of myofascial release with eccentric resistance and without eccentric resistance on pain , range of motion and functional disability in patient with Achilles tendinitis

Who can participate

Age range

25 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Both male and female. * Age limit 25-50 year. * Diagnosed patients by orthopedic surgeon. * Achilles tendon symptoms (pain) present in one limb for a minimum of two months. * Report having pain rated at least 3 out of 10 on a numerical rating scale (NRS-11). * Be able to walk household distances (more than 50 m) without the aid of a walker, crutches or can Exclusion Criteria: * History of Pregnanc. * Having history of rheumatoid arthritis or generalized polyarthritis. * Pervious history of Achilles tendon rupture or surgery i.e arthrodesis , club foot surgery * History of hind foot fracture, or leg-length discrepancy of more than one-half inch. * Taken any manual therapy in last 3 month. * Contraindication to myofacial releas i.e skin burn or disease

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

pain intensity

Timeframe: change in pain intensity score will be measured at baseline , at 2nd week , at 4th week

Range of motion

Timeframe: Change in range of motion score will be measured at baseline , at 2nd week , at 4th week

Functional disability

Timeframe: change in Function disability score will be measured at baseline, at 2nd week , at 4th week

Trial details

NCT IDNCT05550857

SponsorUniversity of Lahore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-28

View on ClinicalTrials.gov More Achilles Tendonitis trials